Board of Directors

  • Scott Tarriff
    Chief Executive Officer, Board Member, Executive Committee

    Mr. Tarriff is the founder and chief executive officer of Eagle Pharmaceuticals. Prior to joining Eagle, Mr. Tarriff held various executive positions at Par Pharmaceutical Companies, Inc. and Bristol-Myers Squibb, both publicly traded companies. At Par, he served as president and chief executive officer from September 2003 to September 2006, and was also a member of the board of directors from 2002 to September 2006.

    more
  • Michael Graves
    Chairman, Executive Committee Chair, Compensation Committee Chair, Audit Committee

    Michael Graves has served as a member of Eagle’s board of directors since November 2013. In January 2012 Mr. Graves joined the board of directors of RiboCor, Inc. and in December 2011, Mr. Graves was appointed chairman of the board of directors of Nanocopoeia, Inc., both private pharmaceutical companies. From May 2007 to July 2011, Mr. Graves served as the chief executive officer and president of Paddock Laboratories, Inc., a pharmaceutical company engaged in the manufacture, distribution and

    more
  • Steven Ratoff
    Board Member, Audit Committee Chair

    Mr. Ratoff has served as a member of our board of directors since March 2007. Since December 2004, Mr. Ratoff has served as a venture partner of ProQuest Investments. Since January 2010, Mr. Ratoff has served as president and chief executive officer of NovaDel Pharma Inc., a private specialty pharmaceutical company, and Mr. Ratoff has served in a number of interim executive positions since joining NovaDel’s board of directors in May 2005. Mr. Ratoff has also served on NovaDel Pharma Inc.’s

    more
  • Sander Flaum
    Board Member, Nominating and Corporate Governance Committee Chair, Compensation Committee

    Sander Flaum has served as a member of our board of directors since February 2008. Since January 2005, Mr. Flaum has served as a principal of Flaum Navigators, a healthcare consultancy firm that he founded. Mr. Flaum has also served as the chief executive officer of Flaum Partners, Inc., a healthcare consultancy firm he founded, since August 2004. From 1991 to 2002, Mr. Flaum served as chief executive officer of Robert A. Becker EURO/RSCG, a predecessor to Euro RSCG Life. Prior to that, Mr.

    more
  • Douglas L. Braunstein
    Board Member, Compensation Committee

    Douglas Braunstein has 30 years of industry experience, currently serving as a managing partner and co-founder of Hudson Executive Capital LP. During his career at JPMorgan Chase & Co., Doug served as CFO, Vice Chairman, a member of the Operating Committee, and Head of Americas Investment Banking and Global M&A, among other roles. Doug is a trustee of Cornell University and a member of Cornell's Investment Committee for the Endowment. He received his B.S. from Cornell University in

    more
  • Robert L. Glenning
    Board Member, Nominating and Corporate Governance Committee, Audit Committee

    Robert L. Glenning has over 30 years of experience in the healthcare industry and currently serves as the President of the Financial Services Division and Chief Financial Officer at Hackensack Meridian Health, the most comprehensive health delivery network in the state of New Jersey with anticipated revenues of over $4 billion annually. He previously served as Executive Vice President and CFO of Hackensack University Health Network. From 2002 – 2007, Robert served as an Executive Vice

    more
  • Richard A. Edlin
    Board Member, Nominating and Corporate Governance Committee

    Mr. Edlin is the Vice Chair, Chair of the Litigation Practice in New York, and a member of the Executive Committee of the law firm Greenberg Traurig, LLP, a top international multi-practice law firm, to the Company’s Board of Directors, and as a member of the Board’s Nominating and Corporate Governance Committee, each effective as of March 17, 2017.

    more